厄洛替尼引起非小细胞肺癌患者发生皮疹的病理机制、临床意义及其治疗

被引：17

作者：

丁燕

刘谦

南娟

周清华

机构：

[1] 天津医科大学总医院,天津市肺癌研究所,天津市肺癌转移与肿瘤微环境重点实验室

来源：

中国肺癌杂志 | 2009年 / 12卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

<正>肺癌是癌症相关死亡的主要原因,而非小细胞肺癌(non-small cell lung cancer,NSCLC)约占肺癌总数的80%。多数NSCLC患者在诊断时即属晚期,即使被诊断为早期的患者,他们中的大部分最终会复发并发生转移。对于晚期疾病,减轻症状并提高患者的生存质量仍

引用

页码：1330 / 1336

页数：7

共 9 条

[1]

Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer [J].

Boeck, Stefan ;

Hausmann, Andreas ;

Reibke, Roland ;

Schulz, Christoph ;

Heinemann, Volker .

ANTI-CANCER DRUGS, 2007, 18 (09) :1109-1111

[2]

Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management [J].

Hu, Jenny C. ;

Sadeghi, Parrish ;

Pinter-Brown, Lauren C. ;

Yashar, Sharona ;

Chin, Melvin W. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) :317-326

[3]

Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006 [J].

Hymes, SR ;

Strom, EA ;

Fife, C .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (01) :28-46

[4]

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies.[J].SiegfriedSegaert;JosepTabernero;OlivierChosidow;ThomasDirschka;JoernElsner;LucaMancini;TimMaughan;Jean‐FranμoisMorere;ArmandoSantoro;AlbertoSobrero;EricVan Cutsem;AlisonLayton.Journal der Deutschen Dermatologischen Gesellschaft.2005, 8

[5]

Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib [J].

Kimura, H ;

Kasahara, K ;

Sekijima, M ;

Tamura, T ;

Nishio, K .

LUNG CANCER, 2005, 50 (03) :393-399

[6]

Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody [J].

Boucher, KW ;

Davidson, K ;

Mirakhur, B ;

Goldberg, J ;

Heymann, WR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) :632-633

[7]

Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer [J].

Reissmann, PT ;

Koga, H ;

Figlin, RA ;

Holmes, EC ;

Salmon, DJ .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (02) :61-70

[8]

Targeting the epidermal growth factor receptor for therapy of carcinomas [J].

Davies, DE ;

Chamberlin, SG .

BIOCHEMICAL PHARMACOLOGY, 1996, 51 (09) :1101-1110

[9]

Inhibition of the Epidermal Growth Factor Receptor Increases Expression of Genes That Stimulate Inflammation;Apoptosis;and Cell Attachment..Woodworth CD;Michael E;et al;.Mol Cancer Ther.2005,

← 1 →